The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs
Abstract
Background Cardiovascular diseases (CVD) represent a heavy economic burden on individuals, health services, and society. Low adherence to antihypertensive (AH) agents is acknowledged as a major contributor to the lack of blood pressure control, and may have a significant impact on clinical outcomes and healthcare costs. Objectives To evaluate the impact of low adherence to AH agents on cardiovascular outcomes and hospitalization costs. Methods A cohort of 59,647 patients with essential hypertension was reconstructed from the Régie de l'assurance maladie du Québec and Med-Echo databases. Subjects included were between 45 and 85 years of age, without any evidence for symptomatic CVD, newly treated with AH agents between 1999 and 2002 and followed-up for a 3-year period. Adherence to AH agents was categorized as >or=80% or Results Patients with low adherence were more likely to have coronary disease (OR, 1.07; 95% confidence interval [CI], 1.00-1.13), cerebrovascular disease (OR, 1.13; 95% CI, 1.03-1.25), and chronic heart failure (OR, 1.42; 95% CI, 1.27-1.58) within the 3-year follow-up period. Among hospitalized patients, low adherence to AH therapy was associated with increased costs by approximately $3574 (95% CI, $2897-$4249) per person within a 3-year period. Conclusions Low adherence to AH agents is correlated with a higher risk of vascular events, hospitalization, and greater healthcare costs. An increased level of adherence to AH agents should provide a better health st…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reinforcing measures aimed at improving adherence to treatment is cost effective. 31,32”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [32]
In the citing paper
“Reinforcing measures aimed at improving adherence to treatment is cost effective.31,32”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [32]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 1×
“The observed relation between good adherence to placebo and mortality supports the importance of the healthy adherer effect, where adherence to medication may be a marker of overall healthy behavior.(37) However, based on the differential class effects of drug adherence on long-term survival, it FIGURE 1.”
BackgroundHypertension Treatment and Control in Five European Countries, Canada, and the United States
Wolf-Maier, K., Cooper, R. S., Kramer, H., Banegas, J. R., Giampaoli, S., Joffres, M. R., Poulter, N., Primatesta, P., Stegmayr, B., & Thamm, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000103630.72812.10 · Cited by 1,083
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,079
A chronic disease score from automated pharmacy data
Von Korff, M., Wagner, E. H., & Saunders, K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90016-g · Cited by 961
Cited by
Items 101–200 of 220
Mancia, G., Mancia, & Schumacher (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s27939 · Cited by 19
Blais, L., Vilain, A., Kettani, F., Forget, A., Lalonde, G., Beauchesne, M.-F., Ducharme, F. M., & Lemière, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005903 · Cited by 17
Self-citationGlucocorticoids in systemic sclerosis: patients’ beliefs and treatment adherence
Iudici, M., Russo, B. F., Mitidieri, M., Cuomo, G., & Valentini, G. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2014.957239 · Cited by 17
Accuracy of Prescription Claims Data in Identifying Truly Nonadherent Patients
Glassberg, M. B., Trygstad, T. K., Wei, D., Robinson, T., & Farley, J. F. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.12.1349 · Cited by 16
Medication adherence issues in patients: focus on cost
Matsui, D. M. (2013) · Clinical Audit · doi:10.2147/ca.s30125 · Cited by 19
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
Duarte-Silva, D., Figueiras, A., Herdeiro, M. T., Rodrigues, A. T., Branco, F., Polónia, J. J., & Figueiredo, I. V. (2014) · Pharmacy Practice · doi:10.4321/s1886-36552014000200005 · Cited by 16
Gentil, L., Vasiliadis, H., Préville, M., & Berbiche, D. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12869 · Cited by 16
Fixed-dose triple-combination treatments in the management of hypertension.
Ram, C. V. S. (2013) · PubMed · Cited by 16
Costa, F. V. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0221-4 · Cited by 15
Belachew, E. A., Netere, A. K., & Sendekie, A. K. (2022) · Asthma Research and Practice · doi:10.1186/s40733-022-00089-1 · Cited by 18
Adherence and Health Care Costs with Single-Pill Fixed-Dose Combinations in Hypertension Management
Hilleman, D. E. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.1.93 · Cited by 17
van der Laan, D. M., Elders, P. J. M., Boons, C. C. L. M., Bosmans, J. E., Nijpels, G., & Hugtenburg, J. G. (2017) · Trials · doi:10.1186/s13063-016-1696-3 · Cited by 17
Visco, V., Finelli, R., Pascale, A. V., Giannotti, R., Fabbricatore, D., Ragosa, N., Ciccarelli, M., & Iaccarino, G. (2017) · PubMed Central · doi:10.14273/unisa-2686 · Cited by 15
Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors
Essayagh, T., Essayagh, M., & Essayagh, S. (2020) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaa002 · Cited by 17
Martin‐Latry, K., Cazaux, J., Lafitte, M., & Couffinhal, T. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3608 · Cited by 13
Rocha, J., Aprikian, A. G., Vanhuyse, M., Cury, F., Hu, J., Prévost, N., & Dragomir, A. (2017) · CMAJ Open · doi:10.9778/cmajo.20160082 · Cited by 12
Self-citationHow do Compliance, Convenience, and Tolerability Affect Blood Pressure Goal Rates?
Erdine, S. E. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261838 · Cited by 15
Després, F., Perreault, S., Lalonde, L., Forget, A., Kettani, F., & Blais, L. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.11.032 · Cited by 15
Self-citationLiguori, Y., Murase, K., & Hamamura, M. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1189408 · Cited by 11
Ritscher, S., Georges, C. M. G., Wunder, C., Wallemacq, P. E., Persu, A., & Toennes, S. W. (2020) · Blood Pressure · doi:10.1080/08037051.2020.1763775 · Cited by 13
REDUCED OUT-OF-POCKET COSTS AND MEDICATION ADHERENCE – A POPULATION-BASED STUDY
Yao, S., Lix, L. M., Shevchuk, Y. M., Teare, G. F., & Blackburn, D. F. (2018) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.22374/1710-6222.25.1.1 · Cited by 11
Unlocking health equity by eliminating copayments for essential antihypertensive medications
Frieden, T. R., Garg, R., Banigbe, B., Choudhury, S. R., Ogbureke, N., Duguma, D., & Tangcharoensathien, V. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103094 · Cited by 11
Evans, C. D., Eurich, D. T., Lu, X., Rémillard, A. J., Shevchuk, Y. M., & Blackburn, D. F. (2012) · American Journal of Hypertension · doi:10.1093/ajh/hps017 · Cited by 10
Kharmats, A. Y., Martinez, T. R., Belli, H. M., Zhao, Y., Mann, D. M., Schoenthaler, A., Voils, C. I., & Blecker, S. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.5.557 · Cited by 11
Racial/Ethnic Disparities in Home Health Care: Charting a Course for Future Research
Davitt, J. K. (2012) · Home Health Care Services Quarterly · doi:10.1080/01621424.2011.641919 · Cited by 13
Boeni, F., Hersberger, K. E., & Arnet, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00220 · Cited by 10
Medication Adherence and Persistence in Hypertension Management
Klootwyk, J., & Sanoski, C. A. (2011) · Cited by 10
Beall, R. F., Leung, A. A. C., Quinn, A. E., Salmon, C., Scory, T. D., Bresee, L. C., & Ronksley, P. E. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14567 · Cited by 13
Yazie, T. S., Yimer, Y. S., Belete, A. M., & Desta, G. T. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00635-w · Cited by 9
Sanfélix‐Gimeno, G., Franklin, J. M., Shrank, W. H., Carlo, M. I., Tong, A. Y., Reisman, L., Matlin, O. S., Brennan, T. A., & Choudhry, N. K. (2014) · Medical Care · doi:10.1097/mlr.0000000000000148 · Cited by 10
Martin‐Latry, K., Latry, P., Pucheu, Y., & Couffinhal, T. (2020) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2020.11.008 · Cited by 8
Gikunda, C. N., Gitonga, L. K., & Kamweru, P. K. (2021) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2021.112002 · Cited by 9
Blecker, S., Schoenthaler, A., Martinez, T. R., Belli, H. M., Zhao, Y., Wong, C., Fitchett, C., Bearnot, H. R., & Mann, D. (2023) · JMIR Research Protocols · doi:10.2196/47930 · Cited by 9
Critical Knowledge Gaps in Iraqi Nurses' Understanding of Antihypertensive Drug Risks
Ali, W. D. A., Hamid, S. S., Sabah, M., Al-Hijaj, Z. M. H., Baker, S., & Atiyah, M. A. (2024) · Academia Open · doi:10.21070/acopen.9.2024.9284 · Cited by 8
Greer, A. E., Milner, K. A., Marcello, R. T., & Mazin, K. (2015) · Educational Gerontology · doi:10.1080/03601277.2015.1048147 · Cited by 8
Dragomir, A., Rocha, J., Vanhuyse, M., Cury, F., Kassouf, W., Hu, J., & Aprikian, A. G. (2017) · Current Oncology · doi:10.3747/co.24.3598 · Cited by 10
Self-citationSmith, J. R., Hillman, L. A., & Drawz, P. E. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1411493 · Cited by 8
Daugherty, S. L., Vupputuri, S. X., Hanratty, R. L., Steiner, J. F., Maertens, J., Blair, I. V., Dickinson, L. M., Helmkamp, L. J., & Havranek, E. P. (2019) · JMIR Research Protocols · doi:10.2196/12498 · Cited by 9
Gikunda, C. N., & Gitonga, L. K. (2019) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2019.93007 · Cited by 9
Abbas, H., Hallit, S. R., Kurdi, M., & Karam, R. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02907-z · Cited by 8
Almaghamsi, S. A., & Alzahrani, K. M. (2024) · Cureus · doi:10.7759/cureus.69522 · Cited by 11
Hospitalizações por hipertensão arterial essencial em caráter de urgência no Brasil, 2008-2012
Santos, S. S., & de Vasconcelos, D. F. S. A. (2014) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v12i4.9191 · Cited by 7
Levin, J. B., Moore, D. J., Depp, C. A., Montoya, J. L., Briggs, F. B. S., Rahman, M., Stange, K. C., Einstadter, D., Weise, C., Conroy, C. M., et al. (2022) · Trials · doi:10.1186/s13063-022-06449-9 · Cited by 12
Leite, M. L. C., A., F. J. O., Filho, A. I. D. L., & Lima‐Costa, M. F. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-725 · Cited by 7
Rakugi, H., Shimizu, K., Nishiyama, Y., Sano, Y., & Umeda, Y. (2017) · Blood Pressure · doi:10.1080/08037051.2017.1412797 · Cited by 7
The Role of Wearable Technologies and Telemonitoring in Managing Vascular Disease
Chan, C., Sounderajah, V., Acharya, A., Normahani, P., Bicknell, C., & Riga, C. (2020) · Vascular and Endovascular Review · doi:10.15420/ver.2019.11 · Cited by 6
Wang, C., Wei, D., & Farley, J. F. (2013) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2013.19.3.258 · Cited by 6
Comparative Effectiveness Analysis of Amlodipine/Renin‐Angiotensin System Blocker Combinations
Ram, C. V. S., Vasey, J. J., Panjabi, S. S., Qian, C., & Quah, R. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00695.x · Cited by 6
Casual Model of Adherence to Therapeutic Regimens among Thais with Hypertension
Pinprapapan, E., Panuthai, S., Vannarit, T., & Srisuphan, W. (2013) · Pacific Rim International Journal of Nursing Research · Cited by 6
Mohan, A., Vadhariya, A., Majd, Z., Esse, T. W., Serna, O., & Abughosh, S. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2020.12.009 · Cited by 6
Beliefs and Adherence in Hypertension and Cardiovascular Protection
Chan, A. H. Y., & Horne, R. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_10 · Cited by 8
Shen, Y., Wang, T., Gao, M., Zhu, X., Zhang, X., He, C. G., Li, Y., & Sun, X. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s194667 · Cited by 11
Chen, S., Swallow, E., Li, N., Faust, E., Kelley, C., Xie, J., & Wu, E. Q. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1013624 · Cited by 5
Castillo, A. F., Davis, A. L., Fischhoff, B., & Krishnamurti, T. (2021) · Health Informatics Journal · doi:10.1177/14604582211059463 · Cited by 6
Rozza, F., Trimarco, V., Izzo, R., Santoro, M. G., Manzi, M. V., Marino, M., Renzo, G. D., & Trimarco, B. (2013) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-013-0013-4 · Cited by 5
Su, M., Haldane, V. E., Upshur, R. E. G., Sullivan, F., Légaré, F., Greiver, M., & Wei, X. (2019) · JMIR Research Protocols · doi:10.2196/13571 · Cited by 9
Monitoring and managing medication adherence in community pharmacies in Quebec, Canada
Fénélon-Dimanche, R., Guénette, L., Yousif, A., Lalonde, G., Beauchesne, M.-F., Collin, J., & Blais, L. (2020) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163520902494 · Cited by 6
Self-citationAntihypertensive Medication Use Trajectories After Bariatric Surgery: A Matched Cohort Study
Passman, J. E., Wall‐Wieler, E., Liu, Y., Zheng, F., & Cohen, J. B. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23054 · Cited by 6
Götzinger, F., Kieble, M., Daudí, A. E., Kunz, M., Lauder, L., Böhm, M., Laufs, U., Mahfoud, F., & Schulz, M. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003789 · Cited by 4
The challenge of therapy adherence in clinical practice
Brotons, C. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac197 · Cited by 4
Management of drug-resistant hypertension as a heterogeneous disorder
Tabrizchi, R. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108875 · Cited by 5
Ahmadi, Z., Shahnazi, H., & Hassanzadeh, A. (2022) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1332_21 · Cited by 5
Kongsa, A., Thongsri, P., Chiangkhong, A., & Chongjarearn, A. (2024) · The Open Public Health Journal · doi:10.2174/0118749445280796240206102656 · Cited by 9
Adherence to antihypertensive drugs and its determinants in an urban setting
Saka, M. H. (2019) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2019.037 · Cited by 3
Issues influencing medication adherence in Black women with hypertension
Abel, W. M. (2011) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 5
Sonawane, K., Qian, J., Garza, K. B., Wright, B. M., Zeng, P., Cazaban, C. M. G., & Hansen, R. A. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12799 · Cited by 4
Adherence to antihypertensive medications in rural Lao PDR: a prospective observational study
Takahashi, E., Vilay, P., Chanthakoumane, K., Pongvongsa, T., Kounnavong, S., Kano, S., Kobayashi, J., & Nonaka, D. (2021) · Tropical Medicine and Health · doi:10.1186/s41182-021-00374-4 · Cited by 4
Langendoen‐Gort, M., Al‐Jabr, H., Hugtenburg, J. G., Rutters, F., de Wit, M., Bhattacharya, D., Abu–Hanna, A., Farmer, A. A., & Elders, P. J. M. (2022) · Trials · doi:10.1186/s13063-022-06491-7 · Cited by 6
Adherence to Antihypertensive Medications: Rate and Predictors
Goweda, R. A., & Shatla, M. M. (2020) · The Egyptian Family Medicine Journal/The Egyptian Family Medicine Journal · doi:10.21608/efmj.2020.90203 · Cited by 2
Active Vaccine and Drug Surveillance: Towards a 100 Million Member System
Bjarnadóttir, M. V., & Czerwinski, D. (2013) · International series in management science/operations research/International series in operations research & management science · doi:10.1007/978-1-4614-6507-2_12 · Cited by 2
The impact of cardiovascular profile on persistence associated with antihypertensive medications
Midy, F., & Rudnichi, A. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12253 · Cited by 2
Cossette, S., Côté, J., Rouleau, G., Robitaille, M., Heppell, S., Mailhot, T., Fontaine, G., Cournoyer, C., Gagnon, M., Gallani, M. C. B. J., et al. (2017) · JMIR Cardio · doi:10.2196/cardio.7342 · Cited by 3
Fakultas Farmasi, U. P., Faramitha, A., Prihartanto, B., Fakultas Farmasi, U. P., Destiani, D. P., & Fakultas Farmasi, U. P. (2017) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2017.6.3.220 · Cited by 4
Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
Bakouni, H., Gentil, L., & Vasiliadis, H. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s195756 · Cited by 4
Roseleur, J., Harvey, G., Stocks, N. P., & Karnon, J. D. (2019) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2017-003971 · Cited by 3
Aldukhayel, A., Almarshoud, S. S., Aldekhail, M., Alkhattaf, M., Alowais, A., & Aldawsari, A. (2022) · Medical Science · doi:10.54905/disssi/v26i129/ms490e2547 · Cited by 2
[Doctor-patient relationship and therapeutic adherence in patients with arterial hypertension].
Peña-Valenzuela, A. N., Ruiz-Cervantes, W., Barrios-Olán, C., & Chávez-Aguilasocho, A. I. (2023) · PubMed Central · Cited by 12
Global Clinical Consequences of Poor Adherence
Perreault, S. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_22 · Cited by 2
Self-citationSelf-Efficacy of Medication Adherence in Hypertensive Patients in Bandung Regency, Indonesia
Wilandika, A., Handayani, A., & Sanusi, S. (2023) · The Malaysian Journal of Nursing · doi:10.31674/mjn.2023.v15isupp1.004 · Cited by 5
Beyna, A. T., Mengesha, A. K., Ayele, H. S., Dajane, F. M., Mule, A. H., Asrie, A. B., Belete, T. M., Getachew, D., Alemayehu, T. T., Tadesse, G., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341140 · Cited by 4
Chham, S., Buffel, V., Ir, P., Ku, G. M., Chhim, S., (69591), W. V. D., van Olmen, J., & Wouters, E. (2026) · BMC Public Health · doi:10.1186/s12889-026-26628-6 · Cited by 4
Aljuhani, M., Almutairi, A. S., Almutairi, R. R., & Alodhialah, A. M. (2026) · Healthcare · doi:10.3390/healthcare14070891 · Cited by 1
Omerza, K. E. (2015) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Despang, P., Schikora, M., & Doehner, W. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01506-0 · Cited by 1
Ramezani, P., Amiri, M., Bagheri, A., & Naderi, F. (2024) · Jundishapur Journal of Health Sciences · doi:10.5812/jjhs-157051 · Cited by 1
Сергиенко, И. В., & Ansheles, A. A. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-1-77-87 · Cited by 2
The effect of adherence on antihypertensive therapy plans in patients with diabetes
Mirghorbani, S., Melouk, S. H., & Mittenthal, J. (2021) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2021.1879321 · Cited by 2
Yazie, T. S., Mengistu, W. E., Asmare, Z., Belete, A. M., Teshome, A. A., & Yimer, Y. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272717 · Cited by 1
RetractedThe contribution of community-based programmes to health
Pardoel, Z. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.925136990 · Cited by 1
Una miglior compliance ai farmaci antipertensivi riduce il rischio cardiovascolare
Corrao, G., Parodi, A. F., Nicotra, F., Zambon, A., Merlino, L. G., Cesana, G., & Mancia, G. (2012) · BOA (University of Milano-Bicocca)
Treatment adherence in hypertension : methodological aspects and new strategies
van Onzenoort, H. A. W. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120627ho
PCV72 Chronic Medication Adherence: Its Association with Health Care Costs
Zhou, S., Carlson, A., Gleason, P. P., Schommer, J. C., Hadsall, R. S., Nyman, J. A., & Ritter, S. T. (2012) · Value in Health · doi:10.1016/j.jval.2012.03.675
Outcomes of Treatment Modifications of Antihypertensive Regimens
Sonawane, K. (2015)
Adesão ao tratamento da pessoa com cardiopatia isquémica
Dias, A. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/ka8z-je74
(The Development of the Economic Model of the Drug Supply of the Population)Preprint
Avxentieva, M., Omelyanovsky, V. V., & Сура, М. В. (2014) · SSRN Electronic Journal · doi:10.2139/ssrn.2597498
Los estudios económicos en enfermedades crónicas de alta prevalencia
Rosselli, D., & Lasalvia, P. (2015) · Acta Médica Colombiana · doi:10.36104/amc.2015.731
Éducation et observance thérapeutique dans l'hypertension artérielle
Bitton, S., Dreyfuss-Tubiana, C., Yannoutsos, A., Lelong, H., Kretz, S., Emmerich, J., & Blacher, J. (2017)
Girolineto, B. M. P. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2015.tde-17042015-092522
Després, F., Perreault, S., Lalonde, L., Kettani, F., & Blais, L. (2014)
Self-citation
Metadata
- Authors
- Dragomir, A., Côté, R., Roy, L., Blais, L., Lalonde, L., Bérard, A., & Perreault, S.
- Affiliations
- Université de Montréal (CA)
- McGill University (CA)
- Corresponding author
- Dragomir, Alice
- Blais, Lucie
- Lalonde, Lyne
- Bérard, Anick
- Perreault, Sylvie
- Venue
- Medical Care
- Published
- 2010-05
- Volume
- 48
- Issue
- 5
- Pages
- 418-425
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W1966704625
- Cited by
- 221
- References
- 41
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 19 · 2021: 6 · 2020: 14 · 2019: 16 · 2018: 13 · 2017: 20 · 2016: 13 · 2015: 14 · 2014: 20 · 2013: 21 · 2012: 20
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- antihypertensive drugs, medication adherence, essential hypertension, cardiovascular disease, hospital costs, coronary disease, cerebrovascular disease, chronic heart failure, health care costs, blood pressure control
- MeSH terms
- Assessment of Medication Adherence, Age Factors, Aged, Aged, 80 and over, Antihypertensive Agents, Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Artery Disease, Drug Therapy, Combination, Female, Heart Failure, Hospitalization, Humans, Hypertension, Insurance Claim Review, Male, Middle Aged, Sex Factors, Cohort Studies, Treatment Outcome, Drug Monitoring, Hospital Charges, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.